<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045260"><TermName>dacarbazine</TermName><TermPronunciation>(duh-KAR-buh-zeen)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat Hodgkin lymphoma and malignant melanoma. It is also being studied in the treatment of other types of cancer. Dacarbazine attaches to DNA in cells and may kill cancer cells. It is a type of alkylating agent. Also called DTIC-Dome.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000705216" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;dacarbazine&quot;" language="en" id="_3"/><MediaLink ref="CDR0000705217" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;dacarbazina&quot;" language="es" id="_4"/><SpanishTermName>dacarbazina</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar el linfoma de Hodgkin y el melanoma maligno. También está en estudio para el tratamiento de otros tipos de cáncer. La dacarbazina se une al ADN de las células y puede destruir células cancerosas. Es un tipo de alquilante. También se llama DTIC-Dome.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2015-09-10</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000649947">Dacarbazine</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
